Search for a trial

A phase 1, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]pacritinib following a single oral dose in healthy male subjects.

To characterize the clearance pathways, the routes of excretion, total recovery of radioactivity, pacritinib and its major metabolites in healthy subjects following administration of a single oral dose of 400 mg [14C]pacritinibTo characterize the…